Venatorx and Roche team up to take on 'superbugs' with new class of antibiotics
November 01, 2021 at 12:11 PM EDT
Venatorx CEO Christopher J. Burns said his company's new class of antibiotics "has the potential to usher in a new wave of antibacterial therapeutics and reset the clock on antimicrobial resistance."
